[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Foot and Mouth Disease (FMD) Vaccines-Global Market Status and Trend Report 2013-2023

May 2018 | 130 pages | ID: FD29B454E20MEN
MIReports Co., Limited

US$ 2,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Foot and Mouth Disease (FMD) Vaccines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Foot and Mouth Disease (FMD) Vaccines industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Foot and Mouth Disease (FMD) Vaccines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Foot and Mouth Disease (FMD) Vaccines worldwide, with company and product introduction, position in the Foot and Mouth Disease (FMD) Vaccines market
Market status and development trend of Foot and Mouth Disease (FMD) Vaccines by types and applications
Cost and profit status of Foot and Mouth Disease (FMD) Vaccines, and marketing status
Market growth drivers and challenges

The report segments the global Foot and Mouth Disease (FMD) Vaccines market as:

Global Foot and Mouth Disease (FMD) Vaccines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Foot and Mouth Disease (FMD) Vaccines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

By the type of Serum
O type
A type
C type
SAT 1 type
SAT 2 type
SAT 3 type
Asia 1 type

Global Foot and Mouth Disease (FMD) Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Pig
Cattle
Sheep
Others

Global Foot and Mouth Disease (FMD) Vaccines Market: Manufacturers Segment Analysis (Company and Product introduction, Foot and Mouth Disease (FMD) Vaccines Sales Volume, Revenue, Price and Gross Margin):

MSD Animal Health
Bayer HealthCare
Sanofi(Merial)
Brilliant Bio Pharma
Agrovet
Inova Biotecnologia Sa?de
IIL
MEVAC
BVI
VETAL
VSVRI
Biog nesis
VECOL
Limor de Colombia
Razi Vaccine & Serum
PVI
CAHIC
Tecon Group
Jinyu Group
Asia Animal Healthcare
Cavet Bio
Shen Lian

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF FOOT AND MOUTH DISEASE (FMD) VACCINES

1.1 Definition of Foot and Mouth Disease (FMD) Vaccines in This Report
1.2 Commercial Types of Foot and Mouth Disease (FMD) Vaccines
  1.2.1 By the type of Serum
  1.2.2 O type
  1.2.3 A type
  1.2.4 C type
  1.2.5 SAT 1 type
  1.2.6 SAT 2 type
  1.2.7 SAT 3 type
  1.2.8 Asia 1 type
1.3 Downstream Application of Foot and Mouth Disease (FMD) Vaccines
  1.3.1 Pig
  1.3.2 Cattle
  1.3.3 Sheep
  1.3.4 Others
1.4 Development History of Foot and Mouth Disease (FMD) Vaccines
1.5 Market Status and Trend of Foot and Mouth Disease (FMD) Vaccines 2013-2023
  1.5.1 Global Foot and Mouth Disease (FMD) Vaccines Market Status and Trend 2013-2023
  1.5.2 Regional Foot and Mouth Disease (FMD) Vaccines Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Foot and Mouth Disease (FMD) Vaccines 2013-2017
2.2 Sales Market of Foot and Mouth Disease (FMD) Vaccines by Regions
  2.2.1 Sales Volume of Foot and Mouth Disease (FMD) Vaccines by Regions
  2.2.2 Sales Value of Foot and Mouth Disease (FMD) Vaccines by Regions
2.3 Production Market of Foot and Mouth Disease (FMD) Vaccines by Regions
2.4 Global Market Forecast of Foot and Mouth Disease (FMD) Vaccines 2018-2023
  2.4.1 Global Market Forecast of Foot and Mouth Disease (FMD) Vaccines 2018-2023
  2.4.2 Market Forecast of Foot and Mouth Disease (FMD) Vaccines by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Foot and Mouth Disease (FMD) Vaccines by Types
3.2 Sales Value of Foot and Mouth Disease (FMD) Vaccines by Types
3.3 Market Forecast of Foot and Mouth Disease (FMD) Vaccines by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Foot and Mouth Disease (FMD) Vaccines by Downstream Industry
4.2 Global Market Forecast of Foot and Mouth Disease (FMD) Vaccines by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Foot and Mouth Disease (FMD) Vaccines Market Status by Countries
  5.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Countries (2013-2017)
  5.1.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2013-2017)
  5.1.3 United States Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  5.1.4 Canada Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  5.1.5 Mexico Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
5.2 North America Foot and Mouth Disease (FMD) Vaccines Market Status by Manufacturers
5.3 North America Foot and Mouth Disease (FMD) Vaccines Market Status by Type (2013-2017)
  5.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2013-2017)
  5.3.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2013-2017)
5.4 North America Foot and Mouth Disease (FMD) Vaccines Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Status by Countries
  6.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Countries (2013-2017)
  6.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2013-2017)
  6.1.3 Germany Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.4 UK Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.5 France Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.6 Italy Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.7 Russia Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.8 Spain Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  6.1.9 Benelux Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
6.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Status by Manufacturers
6.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Status by Type (2013-2017)
  6.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2013-2017)
  6.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2013-2017)
6.4 Europe Foot and Mouth Disease (FMD) Vaccines Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Status by Countries
  7.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2013-2017)
  7.1.3 China Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  7.1.4 Japan Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  7.1.5 India Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  7.1.6 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  7.1.7 Australia Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
7.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Status by Manufacturers
7.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2013-2017)
  7.3.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2013-2017)
7.4 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Foot and Mouth Disease (FMD) Vaccines Market Status by Countries
  8.1.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Countries (2013-2017)
  8.1.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2013-2017)
  8.1.3 Brazil Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  8.1.4 Argentina Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  8.1.5 Colombia Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
8.2 Latin America Foot and Mouth Disease (FMD) Vaccines Market Status by Manufacturers
8.3 Latin America Foot and Mouth Disease (FMD) Vaccines Market Status by Type (2013-2017)
  8.3.1 Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2013-2017)
  8.3.2 Latin America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2013-2017)
8.4 Latin America Foot and Mouth Disease (FMD) Vaccines Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Status by Countries
  9.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Countries (2013-2017)
  9.1.3 Middle East Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
  9.1.4 Africa Foot and Mouth Disease (FMD) Vaccines Market Status (2013-2017)
9.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Status by Manufacturers
9.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2013-2017)
9.4 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF FOOT AND MOUTH DISEASE (FMD) VACCINES

10.1 Global Economy Situation and Trend Overview
10.2 Foot and Mouth Disease (FMD) Vaccines Downstream Industry Situation and Trend Overview

CHAPTER 11 FOOT AND MOUTH DISEASE (FMD) VACCINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Foot and Mouth Disease (FMD) Vaccines by Major Manufacturers
11.2 Production Value of Foot and Mouth Disease (FMD) Vaccines by Major Manufacturers
11.3 Basic Information of Foot and Mouth Disease (FMD) Vaccines by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Foot and Mouth Disease (FMD) Vaccines Major Manufacturer
  11.3.2 Employees and Revenue Level of Foot and Mouth Disease (FMD) Vaccines Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 FOOT AND MOUTH DISEASE (FMD) VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 MSD Animal Health
  12.1.1 Company profile
  12.1.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.1.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of MSD Animal Health
12.2 Bayer HealthCare
  12.2.1 Company profile
  12.2.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.2.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Bayer HealthCare
12.3 Sanofi(Merial)
  12.3.1 Company profile
  12.3.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.3.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Sanofi(Merial)
12.4 Brilliant Bio Pharma
  12.4.1 Company profile
  12.4.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.4.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Brilliant Bio Pharma
12.5 Agrovet
  12.5.1 Company profile
  12.5.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.5.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Agrovet
12.6 Inova Biotecnologia Sa?de
  12.6.1 Company profile
  12.6.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.6.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Inova Biotecnologia Sa?de
12.7 IIL
  12.7.1 Company profile
  12.7.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.7.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of IIL
12.8 MEVAC
  12.8.1 Company profile
  12.8.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.8.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of MEVAC
12.9 BVI
  12.9.1 Company profile
  12.9.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.9.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of BVI
12.10 VETAL
  12.10.1 Company profile
  12.10.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.10.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of VETAL
12.11 VSVRI
  12.11.1 Company profile
  12.11.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.11.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of VSVRI
12.12 Biog nesis
  12.12.1 Company profile
  12.12.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.12.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Biog nesis
12.13 VECOL
  12.13.1 Company profile
  12.13.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.13.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of VECOL
12.14 Limor de Colombia
  12.14.1 Company profile
  12.14.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.14.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Limor de Colombia
12.15 Razi Vaccine & Serum
  12.15.1 Company profile
  12.15.2 Representative Foot and Mouth Disease (FMD) Vaccines Product
  12.15.3 Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin of Razi Vaccine & Serum
12.16 PVI
12.17 CAHIC
12.18 Tecon Group
12.19 Jinyu Group
12.20 Asia Animal Healthcare
12.21 Cavet Bio
12.22 Shen Lian

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF FOOT AND MOUTH DISEASE (FMD) VACCINES

13.1 Industry Chain of Foot and Mouth Disease (FMD) Vaccines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF FOOT AND MOUTH DISEASE (FMD) VACCINES

14.1 Cost Structure Analysis of Foot and Mouth Disease (FMD) Vaccines
14.2 Raw Materials Cost Analysis of Foot and Mouth Disease (FMD) Vaccines
14.3 Labor Cost Analysis of Foot and Mouth Disease (FMD) Vaccines
14.4 Manufacturing Expenses Analysis of Foot and Mouth Disease (FMD) Vaccines

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference


More Publications